Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Ipca Laboratories Limited
No Price
Closing Price XBOM 28.04.2026:
1.539,10 INR
28.04.2026 09:59
Current Prices from Ipca Laboratories Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NSE
IPCALAB.NS
INR
28.04.2026 09:59
1.537,00 INR
-4,30 INR
-0,28 %
MSE
IPCALAB.BO
INR
28.04.2026 09:59
1.539,10 INR
-2,20 INR
-0,14 %
Share Float & Liquidity
Free Float58,41 %
Shares Float148,18 M
Shares Outstanding253,7 M
Company Profile for Ipca Laboratories Limited Share
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.
